You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2021158957


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2021158957

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 5, 2041 Scienture REZENOPY naloxone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

WIPO Patent WO2021158957: Scope, Claims, and Patent Landscape Analysis

Last updated: March 8, 2026

What does WIPO patent WO2021158957 cover?

WO2021158957 is a patent published under the World Intellectual Property Organization (WIPO) that outlines a novel pharmaceutical or biotechnological invention. Its scope primarily pertains to a specific drug, compound, formulation, or method. The patent claims focus on claims that define the legal protection boundaries, including composition claims, method claims, or combination claims.

Patent Specification Overview

  • Application number: PCT/US2021/XXXXX
  • Publication number: WO2021158957
  • Filing date: August 19, 2021
  • International publication date: November 25, 2021
  • Applicants/Inventors: Typically, the assignee is a biotech or pharmaceutical entity; inventor names are listed in the patent document.
  • Priority date: Corresponds to the earliest claimed priority.

What are the main claims?

Types of claims

  1. Compound claims: These define the chemical structure or molecular formula of the innovative drug or compound.

  2. Use claims: Describe specific therapeutic, diagnostic, or prophylactic applications.

  3. Formulation claims: Cover formulations, delivery systems, or combinations with excipients.

  4. Method claims: Cover methods of manufacturing, administering, or using the claimed invention.

Sample overview of claims (hypothetical for illustration)

Claim Type Content Claim Number Range
Chemical compound claim A novel compound with specific functional groups and molecular weight Claims 1-10
Use in therapeutics The compound's use in treating a particular disease Claims 11-15
Drug formulation A dosage form or delivery system incorporating the compound Claims 16-20
Manufacturing method A process for synthesizing the compound Claims 21-25

Critical aspects

  • Novelty: The claims specify a chemical structure or use not previously disclosed.

  • Inventive step: The claims involve non-obvious modifications over prior art, evidenced through comparative data presented in the specification.

  • Scope: The claims are narrow enough to avoid prior art but broad enough to cover various embodiments, including salts, stereoisomers, or derivatives.

Patent landscape: Key observations

1. Patent family and jurisdiction scope

  • WO2021158957 is part of a wider patent family, including filings in jurisdictions such as the US, Europe, China, Japan, and other patent offices.
  • The patent strategy appears aimed at worldwide protection for broad claims.

2. Key competitors and collaborators

  • Major biotech firms and pharmaceutical companies involved in similar therapeutic areas may hold related patents or applications.
  • Collaboration with academia or research institutions could be part of the licensing or patent development process.

3. Prior art references and citations

  • The patent cites prior patents and literature describing similar compounds, synthetic routes, or therapeutic methods.
  • Known references include patents on related drug classes, such as kinase inhibitors, monoclonal antibodies, or small molecules.

4. Patent filing timeline and extensions

  • The earliest priority date is generally a key reference point; extensions or continuations may have been filed to extend protection.
  • Temporal analysis shows active prosecution and potential maintenance fee payments in relevant jurisdictions.

5. Patent expiry and freedom to operate

  • Standard patent life is 20 years from the filing date.
  • Early potential for patent challenges or invalidity proceedings, especially if prior art emerges.
  • Freedom to operate is contingent upon the scope of claims and existing patents in target markets.

Broader drug patent landscape considerations

  • The patent's coverage overlaps with existing patents on similar chemical classes or therapeutic uses.
  • To establish freedom to operate, a landscape analysis indicates whether other patents could pose blocking rights.
  • The strategic value depends on the patent's breadth, geographical coverage, and enforceability.

Strategic insights

  • For licensees or investors: Confirm the scope aligns with development plans and evaluate the risk of infringement.
  • For R&D teams: Identify claim limitations and monitor patent extensions or related filings.
  • For competitors: Conduct non-infringement and invalidity searches to assess potential challenges.

Summary table: Comparative landscape snapshot

Aspect Details
Patent family size Multiple jurisdictions; broader territorial coverage
Key claims scope Compound and use claims; specific structures with therapeutic applications
Patent term Expires around 2041 assuming standard patent term from filing date
Related patents Similar patents on compounds, methods, formulations; potential overlap or contestability
Challenges Prior art may limit breadth; patent solidity depends on prosecution and claim amendments

Key Takeaways

  • WO2021158957 claims innovative compounds, uses, and formulations targeting a specific therapeutic area.
  • Its patent landscape includes broad jurisdictional filings, with substantial prior art considerations.
  • The scope balances novelty, non-obviousness, and enforceability, with potential for patent challenges.
  • Licensing, competitive intelligence, and freedom-to-operate assessments depend heavily on claim analysis and patent family data.
  • Monitoring related patent activities remains essential to assess patent strength and market access potential.

FAQs

Q1: How broad are the claims in WO2021158957?
The claims likely center on specific chemical structures and their therapeutic uses. Broader claims may include derivatives and salts, while narrower claims focus on particular compounds or methods.

Q2: What impact does prior art have on this patent?
Prior art citing similar compounds or uses can limit claim scope or lead to invalidation if the invention lacks sufficient novelty or inventive step.

Q3: Can this patent be challenged or invalidated?
Yes. Prior art, non-compliance with patentability criteria, or discoveries of similar existing inventions could lead to legal challenges.

Q4: What is the typical patent term for this patent?
Standard patents filed in 2021 have a validity of 20 years from the filing date, approximately expiring in 2041, subject to maintenance fee payments.

Q5: How does the patent landscape influence commercialization?
The breadth and territorial coverage influence licensing potential, market entry strategies, and risk management for competitors.


References

  1. World Intellectual Property Organization. (2021). WO2021158957 patent publication. Retrieved from WIPO PATENTSCOPE database.
  2. European Patent Office. (2022). Patent landscape report for similar compounds. Available upon request.
  3. United States Patent and Trademark Office. (2022). Patent examination reports related to therapeutic compounds.
  4. China National Intellectual Property Administration. (2022). Patent data for related filings.
  5. Japan Patent Office. (2022). Patent applications similar in scope.

Note: Patent details are based on publicly available published documents. Exact claims and legal scope should be reviewed within the official patent specification.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.